跳至主要内容
临床试验/JPRN-UMIN000036424
JPRN-UMIN000036424已完成未知

An observational study to evaluate clinical utility of the pursuit of RAS status using ctDNA analysis to investigate the optimal patient population for anti-EGFR re-challenge therapy - REMARRY Study

ational Cancer Center Hospital East0 个研究点目标入组 180 人开始时间: 2019年4月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Severe comorbidity. (a)Active multiple cancer (b)Uncontroled central nervous system or leptomeningeal metastasis (c)Mental illness or mental symptoms that would interfere with participation in the study 2)Any patients who are regarded as inadequate for anti-EGFR monoclonal antibody re-challenge by investigators. 3)Intolerant to previous irinotecan therapy. 4)Comorbidity or history of severe pulmonary disease. 5)Men/women who are unwilling to avoid pregnancy. Women who are pregnant or breastfeeding. Women with a positive pregnancy test. 6)Active HCV or HIV infection. 7)Any other patients who are regarded as inadequate for study enrollment by investigators.

研究者

发起方
ational Cancer Center Hospital East

相似试验